SHREVEPORT, La. - Giant cell arteritis, also known as temporal arteritis, is a less common condition where people get inflammation of the arteries that go to the head and neck. Symptoms include, head ...
Learn about polymyalgia rheumatica, temporal arteritis, their symptoms, causes, and treatment options to manage pain, stiffness, and inflammation effectively ...
In one study of 161 patients with biopsy-proven GCA followed up for 11 years, the prevalence of visual ischemic complications was 26.1% and the prevalence of irreversible blindness, mainly due to ...
For most of us, the phrase "stroke of the eye" sounds like a metaphor. But for UK HealthCare's Jagannadha "Jay" Avasarala, ...
(RTTNews) - AbbVie Inc. (ABBV), Wednesday announced Health Canada has issued a Notice of Compliance for RINVOQ for the treatment of adults with giant cell arteritis, both used in combination with a ...
RINVOQ is the first and only oral Janus kinase (JAK) inhibitor approved in the European Union (EU) to treat adult patients with giant cell arteritis (GCA) The approval is supported by data from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback